Carregant...
Management of Morgellons Disease With Low-Dose Trifluoperazine
This medical record review examines the novel use of low-dose trifluoperazine, a high-potency typical antipsychotic, in a cohort of patients with Morgellons disease.
Guardat en:
| Publicat a: | JAMA Dermatol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Medical Association
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5839272/ https://ncbi.nlm.nih.gov/pubmed/29322188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.5175 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|